Page 90 - 20211214_OHKF_Health_Finance_Research_Report_E (1)

Table 3.5
Strategic goal of reinforcing PPPs

Action Target for 2021–22

Provide additional patient choices Provide PPP programmes for patients by 1Q22, including
through selected PPP programmes [1]
• 750 cataract surgeries ( 15.4%)
➞
• 336 haemodialysis places ( 9.5%) [1]
➞
• 50,730 Radi Collaboration ( 123.2%) [2]
➞
• 42,280 GOPC patient capacities ( 15%) [1]
➞
• 64 beds for infirmary service ( 19.8%) [1]
➞
• 1,800 colonoscopies ( 38.5%) [1]
➞
• 2,000 glaucoma patient capacities ( 53.8%) [1]
➞
Continue new PPP programmes that Provide PPP programmes for patients by 1Q22, including
were developed to divert a portion of • 277 case capacities for radiotherapy service
public hospital patients to receive
treatment at the private sector during • 120 case capacities for trauma operative service
COVID-19 • 120 case capacities for breast cancer operative
service
Notes: [1] Percentage increase is calculated based on 2020–21 planned provisions (Legislative Council of the HKSAR, 2021)
[2] Percentage increase is calculated based on 2019–20 actual provisions, because for Radi Collaboration, the
2019–20 actual provision is 22,728, whilst the 2020–21 planned provision is 49,200, meaning the planned
provisions have more than doubled in 2020–21 from 2019–20 (Legislative Council of the Hong Kong SAR, 2021)
Source: HA, 2021a

3.2 PRIMARY HEALTHCARE FINANCING

PPPs as discussed in section 3.1 illustrate that the Government has acknowledged concerns
over health system sustainability and is looking beyond relying on the public sector to improve
population access to healthcare. As heavy focus continues to be placed upon primary
healthcare (PHC) development in Hong Kong, how PHC is financed, whether Hong Kong’s
health financing organisation supports the promotion of primary care uptake, and the
potential role for PPPs warrants further discussion. To improve access to affordable primary
care services in a timely manner, Hong Kong would benefit from an assessment of its current
investment in PHC. This section discusses both international and domestic practices in PHC
spending, trends in PHC spending, strengths and limitations of these practices, and the
implications of Hong Kong’s public-private split in PHC contributions on the future
development of health financing policies.

88